FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2402643145> ?p ?o ?g. }

• W2402643145 endingPage "1086" @default.
• W2402643145 startingPage "1081" @default.
• W2402643145 abstract "Objective: Few data are available on the relevance of adalimumab (ADA) trough serum levels and anti-ADA antibodies (AAA) during long-term follow-up of patients with Crohn’s Disease (CD), and their association with disease outcome. In this study, our aim was to assess ADA trough serum levels and the presence of AAA according to disease activity and clinical response during long-term follow-up in a series of patients with CD treated with ADA monotherapy.Material and methods: We prospectively evaluated 23 consecutive, infliximab-naïve CD patients who achieved clinical remission/response after induction and were in maintenance treatment with ADA, and who were followed-up for at least 72 weeks. Blood samples were drawn at standardized time points to assess ADA through levels, AAA.Results: At week 48, we found significantly (p = 0.027) different ADA trough serum levels in patients in remission (10.1 mcg/mL), mild (7.4 mcg/mL), and moderate/severe disease (4.5 mcg/mL). Median ADA trough levels were significantly lower in patients with AAA (3.7 mcg/mL versus 9.3 mcg/mL, p = 0.006). At the end of follow-up (median 102 weeks, range 73–112 weeks), ADA trough serum concentrations were significantly higher (11.9 mcg/mL) as compared to patients with mild and moderate/severe disease (5.5 mcg/mL, p = 0.0002). Furthermore, median ADA trough concentrations showed a trend towards lower levels in AAA positive patients (5.2 mcg/mL versus 7.2 mcg/mL, p = 0.371).Conclusions: Our results emphasize the relevance of therapeutic drug monitoring in CD patients on biologic treatment. ADA trough serum levels and the presence of AAA are important features in the management of patients on ADA treatment." @default.
• W2402643145 created "2016-06-24" @default.
• W2402643145 creator A5001660061 @default.
• W2402643145 creator A5005997471 @default.
• W2402643145 creator A5014172694 @default.
• W2402643145 creator A5019578005 @default.
• W2402643145 creator A5033229461 @default.
• W2402643145 creator A5047303862 @default.
• W2402643145 creator A5058946827 @default.
• W2402643145 creator A5074099993 @default.
• W2402643145 date "2016-05-20" @default.
• W2402643145 modified "2023-09-26" @default.
• W2402643145 title "Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn’s disease" @default.
• W2402643145 cites W1978593886 @default.
• W2402643145 cites W1991810959 @default.
• W2402643145 cites W2003904406 @default.
• W2402643145 cites W2019462334 @default.
• W2402643145 cites W2022661087 @default.
• W2402643145 cites W2026116536 @default.
• W2402643145 cites W2030638161 @default.
• W2402643145 cites W2038017077 @default.
• W2402643145 cites W2046190793 @default.
• W2402643145 cites W2051028531 @default.
• W2402643145 cites W2072640801 @default.
• W2402643145 cites W2072806283 @default.
• W2402643145 cites W2097183141 @default.
• W2402643145 cites W2104160273 @default.
• W2402643145 cites W2111018767 @default.
• W2402643145 cites W2115112939 @default.
• W2402643145 cites W2115531366 @default.
• W2402643145 cites W2118088660 @default.
• W2402643145 cites W2118559127 @default.
• W2402643145 cites W2121609590 @default.
• W2402643145 cites W2137775651 @default.
• W2402643145 cites W2152026434 @default.
• W2402643145 cites W2159143303 @default.
• W2402643145 cites W2171341132 @default.
• W2402643145 cites W2188248802 @default.
• W2402643145 cites W2320652365 @default.
• W2402643145 cites W2321453230 @default.
• W2402643145 cites W2323383014 @default.
• W2402643145 doi "https://doi.org/10.3109/00365521.2016.1157894" @default.
• W2402643145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27207330" @default.
• W2402643145 hasPublicationYear "2016" @default.
• W2402643145 type Work @default.
• W2402643145 sameAs 2402643145 @default.
• W2402643145 citedByCount "31" @default.
• W2402643145 countsByYear W24026431452017 @default.
• W2402643145 countsByYear W24026431452018 @default.
• W2402643145 countsByYear W24026431452019 @default.
• W2402643145 countsByYear W24026431452020 @default.
• W2402643145 countsByYear W24026431452021 @default.
• W2402643145 countsByYear W24026431452022 @default.
• W2402643145 countsByYear W24026431452023 @default.
• W2402643145 crossrefType "journal-article" @default.
• W2402643145 hasAuthorship W2402643145A5001660061 @default.
• W2402643145 hasAuthorship W2402643145A5005997471 @default.
• W2402643145 hasAuthorship W2402643145A5014172694 @default.
• W2402643145 hasAuthorship W2402643145A5019578005 @default.
• W2402643145 hasAuthorship W2402643145A5033229461 @default.
• W2402643145 hasAuthorship W2402643145A5047303862 @default.
• W2402643145 hasAuthorship W2402643145A5058946827 @default.
• W2402643145 hasAuthorship W2402643145A5074099993 @default.
• W2402643145 hasConcept C126322002 @default.
• W2402643145 hasConcept C139719470 @default.
• W2402643145 hasConcept C141071460 @default.
• W2402643145 hasConcept C162324750 @default.
• W2402643145 hasConcept C188816634 @default.
• W2402643145 hasConcept C2777138892 @default.
• W2402643145 hasConcept C2779134260 @default.
• W2402643145 hasConcept C2779280984 @default.
• W2402643145 hasConcept C2780132546 @default.
• W2402643145 hasConcept C2909675724 @default.
• W2402643145 hasConcept C2911091166 @default.
• W2402643145 hasConcept C31785415 @default.
• W2402643145 hasConcept C32239851 @default.
• W2402643145 hasConcept C71924100 @default.
• W2402643145 hasConcept C90924648 @default.
• W2402643145 hasConceptScore W2402643145C126322002 @default.
• W2402643145 hasConceptScore W2402643145C139719470 @default.
• W2402643145 hasConceptScore W2402643145C141071460 @default.
• W2402643145 hasConceptScore W2402643145C162324750 @default.
• W2402643145 hasConceptScore W2402643145C188816634 @default.
• W2402643145 hasConceptScore W2402643145C2777138892 @default.
• W2402643145 hasConceptScore W2402643145C2779134260 @default.
• W2402643145 hasConceptScore W2402643145C2779280984 @default.
• W2402643145 hasConceptScore W2402643145C2780132546 @default.
• W2402643145 hasConceptScore W2402643145C2909675724 @default.
• W2402643145 hasConceptScore W2402643145C2911091166 @default.
• W2402643145 hasConceptScore W2402643145C31785415 @default.
• W2402643145 hasConceptScore W2402643145C32239851 @default.
• W2402643145 hasConceptScore W2402643145C71924100 @default.
• W2402643145 hasConceptScore W2402643145C90924648 @default.
• W2402643145 hasIssue "9" @default.
• W2402643145 hasLocation W24026431451 @default.
• W2402643145 hasLocation W24026431452 @default.
• W2402643145 hasOpenAccess W2402643145 @default.
• W2402643145 hasPrimaryLocation W24026431451 @default.

• next